Successful therapy starts with the right device

Successful therapy starts with the right device

We are always interested in engaging with you.

Let us know how we can help.

1
Select your area of interest
2
Contact details

Philips, following consultation with the Therapeutic Goods Administration (TGA), announced it is conducting an Urgent Product Defect Correction for specific devices in the sleep and respiratory care portfolio. For more information please 

click here or call 1800 009 579.

References

  1. 2015 User Preference Questionnaire, data on file.
  2. Mask does not directly contact the bridge of the nose or nostrils.
  3. In a retrospective review conducted by Philips Respironics of approximately 15,000 System One patients, patients who used SleepMapper, which has been rebranded DreamMapper, demonstrated 22% greater adherence to the therapy than patients who did not use SleepMapper. To see which therapy devices are compatible with DreamMapper, visit www.dreammapper.com/compatible .

ALWAYS FOLLOW THE DIRECTIONS FOR USE.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.